Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Related Citations for PubMed (Select 20025038)

1.

Embryo-fetal developmental toxicity study design for pharmaceuticals.

Wise LD, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Lerman SA, Ooshima Y, Stump DG.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):418-28. doi: 10.1002/bdrb.20214. Review.

PMID:
20025038
2.

Pre- and postnatal developmental toxicity study design for pharmaceuticals.

Bailey GP, Wise LD, Buschmann J, Hurtt M, Fisher JE.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):437-45. doi: 10.1002/bdrb.20217. Review.

PMID:
20025040
3.

The nonclinical fertility study design for pharmaceuticals.

Lerman SA, Hew KW, Stewart J, Stump DG, Wise LD.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):429-36. doi: 10.1002/bdrb.20221. Review.

PMID:
20025039
4.

Introduction to special issue on developmental and reproductive toxicity study designs for pharmaceuticals.

Wise LD.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):417. doi: 10.1002/bdrb.20228. No abstract available.

PMID:
20025037
5.

Developmental and reproductive toxicology studies in nonhuman primates.

Chellman GJ, Bussiere JL, Makori N, Martin PL, Ooshima Y, Weinbauer GF.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):446-62. doi: 10.1002/bdrb.20216. Review.

PMID:
20025046
6.

Juvenile animal toxicity study designs to support pediatric drug development.

Cappon GD, Bailey GP, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Ooshima Y, Stump DG, Hurtt ME.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):463-9. doi: 10.1002/bdrb.20220. Review.

PMID:
20025047
7.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
8.

The ICH S5(R2) guideline for the testing of medicinal agents.

Wise LD.

Methods Mol Biol. 2013;947:1-11. doi: 10.1007/978-1-62703-131-8_1.

PMID:
23138891
9.

Developmental and reproductive toxicity studies on artemisone.

Schmuck G, Klaus AM, Krötlinger F, Langewische FW.

Birth Defects Res B Dev Reprod Toxicol. 2009 Apr;86(2):131-43. doi: 10.1002/bdrb.20192.

PMID:
19306395
10.

Reproductive toxicity testing for pharmaceuticals under ICH.

Barrow PC.

Reprod Toxicol. 2009 Sep;28(2):172-9. doi: 10.1016/j.reprotox.2009.03.013. Epub 2009 Apr 9.

PMID:
19631153
11.

Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.

Knudsen TB, Martin MT, Kavlock RJ, Judson RS, Dix DJ, Singh AV.

Reprod Toxicol. 2009 Sep;28(2):209-19. doi: 10.1016/j.reprotox.2009.03.016. Epub 2009 Apr 10.

PMID:
19446433
12.

Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.

Serabian MA, Pilaro AM.

Toxicol Pathol. 1999 Jan-Feb;27(1):27-31. Review.

13.

Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits.

Patyna S, Haznedar J, Morris D, Freshwater K, Peng G, Sukbuntherng J, Chmielewski G, Matsumoto D.

Birth Defects Res B Dev Reprod Toxicol. 2009 Jun;86(3):204-13. doi: 10.1002/bdrb.20194.

PMID:
19294680
14.

Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.

Clark RL, White TE, A Clode S, Gaunt I, Winstanley P, Ward SA.

Birth Defects Res B Dev Reprod Toxicol. 2004 Dec;71(6):380-94.

PMID:
15617018
15.

Different embryo-fetal toxicity effects for three VLA-4 antagonists.

Crofts F, Pino M, DeLise B, Guittin P, Barbellion S, Brunel P, Potdevin S, Bergmann B, Hofmann T, Lerman S, Clark RL.

Birth Defects Res B Dev Reprod Toxicol. 2004 Apr;71(2):55-68.

PMID:
15098199
16.

Developmental toxicity testing: protecting future generations?

Bailey J.

Altern Lab Anim. 2008 Dec;36(6):718-21.

18.

Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals.

Martin PL, Breslin W, Rocca M, Wright D, Cavagnaro J.

Birth Defects Res B Dev Reprod Toxicol. 2009 Jun;86(3):176-203. doi: 10.1002/bdrb.20197. Review.

PMID:
19462404
19.

The predictivity of preliminary embryo-fetal development (EFD) studies: results of a retrospective survey in Japanese pharmaceutical companies.

Okahashi N, Ikeda T, Kai S, Komatsu S, Matsui H, Yamashita Y, Yamamoto K, Sagami F.

J Toxicol Sci. 2010 Feb;35(1):21-31.

20.

Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.

Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.

Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):5-26. Review.

PMID:
12852480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk